Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells.

Stem Cells Int · 2021 · PMC8741398 · PMID 35003268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Second, the researchers continuously administered Rg1 (15 mg/kg/day) to CY-induced myelosuppressed mice (splenectomy) for 7 days [ 27 ], and the results showed that Rg1 could not effectively increase the percentage of bone marrow Lin − Sca-1 + c-Kit + HSCs (no significant difference), but an increasing trend was observed.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.